Protein expression of Skp2 in osteosarcoma and its relation with prognosis.
- Author:
Qian-de LIAO
1
;
Da ZHONG
;
Qun CHEN
Author Information
1. Department of Orthopedics, Xiangya Hospital, Central South University, Changsha 410008, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Biomarkers, Tumor;
Bone Neoplasms;
metabolism;
pathology;
Female;
Humans;
Male;
Middle Aged;
Neoplasm Invasiveness;
Neoplasm Metastasis;
Osteosarcoma;
metabolism;
pathology;
Prognosis;
Proliferating Cell Nuclear Antigen;
biosynthesis;
genetics;
S-Phase Kinase-Associated Proteins;
biosynthesis;
genetics;
Tumor Cells, Cultured
- From:
Journal of Central South University(Medical Sciences)
2008;33(7):606-611
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the expression of Skp2 and its relation with P27 expression, clinic pathologic features, and prognostic indicator in osteosarcoma.
METHODS:We collected osteosarcoma specimen from 52 patients (29 males and 23 females), who were all treated by radical resection of tumor. The expression of Skp2 and P27 was determined by SP immunohistochemistry. Forty-four patients were followed up for 4 to approximately 84(mean = 31.2)months, while the other 8 patients were lost. Twenty of them survived over 5 years and 24 died.
RESULTS:In osteosarcoma, Skp2 highly expressed (mean value was 1.74). Expression intensity of Skp2 at the stage III was obviously higher than that of the stage II(IIa and IIb) (P < 0.05). Skp2 expression was correlated with the relapse, metastasis, and 5-year survival in osteosarcoma (P < 0.05), but not with different pathologic types, sex, or age(P > 0.05). The expressions of skp2 and P27 were negative correlation in osteosarcoma (r = -0.907, P < 0.05).
CONCLUSION:Skp2 plays an important role in the occurrence and development of osteocarcoma by causing the degradation of P27, and can be an important prognostic indicator in osteosarcoma.
